CRON vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 06, 2026

CRON

62.2
AI Score
VS
CRON Wins

PCRX

56.6
AI Score

Investment Advisor Scores

CRON

62score
Recommendation
BUY

PCRX

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CRON PCRX Winner
Forward P/E 27.5482 8.6655 PCRX
PEG Ratio 0 11.2121 Tie
Revenue Growth 40.1% 5.0% CRON
Earnings Growth 126.8% -30.0% CRON
Tradestie Score 62.2/100 56.6/100 CRON
Profit Margin -1.1% 0.7% PCRX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CRON

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.